The Federal Court of Appeal in Seedlings Life Science Ventures, LLC v. Pfizer Canada ULC, 2021 FCA 154 held that overbreadth remains a proper ground of invalidity. This webinar will help attendees understand the basis for assessing overbreadth and provide practical tips for drafting patents to avoid disclosure pitfalls in Canada.